Market revenue in 2023 | USD 798.7 million |
Market revenue in 2030 | USD 1,503.2 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.93% in 2023. Horizon Databook has segmented the Japan regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is the second largest pharmaceutical market after the U.S., thus driving the Regulatory affairs outsourcing market within the region.
The region is expected to dominate the Regulatory affairs outsourcing market during the forecast period in the Asia Pacific region, owing to rising demand for new and cost-effective medicines, which may attract investments from biopharmaceutical companies in this region.
Rising demand for generics due to government support and improvement in regulatory approval processes are expected to result in increase in market entrants, thereby propelling the demand for regulatory services in this region.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Japan regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account